Details
Stereochemistry | RACEMIC |
Molecular Formula | C14H14Cl2N2O |
Molecular Weight | 297.18 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC(Cl)=C(C=C1)C(CN2C=CN=C2)OCC=C
InChI
InChIKey=PZBPKYOVPCNPJY-UHFFFAOYSA-N
InChI=1S/C14H14Cl2N2O/c1-2-7-19-14(9-18-6-5-17-10-18)12-4-3-11(15)8-13(12)16/h2-6,8,10,14H,1,7,9H2
Molecular Formula | C14H14Cl2N2O |
Molecular Weight | 297.18 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Enilconazole is a synthetic broad-spectrum antimycotic with a high activity against most of the common dermatophytes and various other fungi and yeasts. It is a selective inhibitor of ergosterol biosynthesis, an essential component of the cell membrane of fungi and yeasts. This results in irreversible changes which are the origin of the fungicidal effect. Enilconazole is marketed under the brand name Imaverol among others. Imaverol concentrated solution is a synthetic antimycotic with a potent antifungal action against dermatophytes such as: Trichophyton verrucosum, Trichophyton mentagrophytes, Trichophyton equinum, and Microsporum canis in horses and dogs.
Originator
Sources: http://www.beckerdata.com/reg/ | https://archive.epa.gov/pesticides/reregistration/web/pdf/2325fact.pdf
Curator's Comment: # Janssen Pharmaceutica (Johnson & Johnson)
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL340 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19070657 |
|||
Target ID: CHEMBL2231 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19070657 |
|||
Target ID: O75469|||Q9UJ26 Gene ID: 8856.0 Gene Symbol: NR1I2 Target Organism: Homo sapiens (Human) |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | IMAVEROL Approved UseIMAVEROL concentrated solution is a synthetic antimycotic with a potent antifungal action against dermatophytes such as: Trichophyton verrucosum, Trichophyton mentagrophytes, Trichophyton equinum, and Microsporum canis in horses and dogs. Launch Date2012 |
PubMed
Title | Date | PubMed |
---|---|---|
Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro. | 2000 Jun |
|
Evaluation of topically applied enilconazole for the treatment of dermatophytosis in a Persian cattery. | 2002 Feb |
|
Evaluation of the efficacy of oral lufenuron combined with topical enilconazole for the management of dermatophytosis in catteries. | 2002 Jun 8 |
|
Intranasal infusion of enilconazole for treatment of sinonasal aspergillosis in dogs. | 2002 Nov 15 |
|
Use of computed tomography to predict the outcome of a noninvasive intranasal infusion in dogs with nasal aspergillosis. | 2003 Apr |
|
[Canine onychomycosis produced by Microsporum gypseum. A case report]. | 2003 Dec |
|
Allergic contact dermatitis from 1-[2-(2,4-dichlorophenyl)-2-(2-propenyloxy) ethyl]-1H-imidazole in a water-based metalworking fluid. | 2003 May |
|
Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells. | 2004 Apr |
|
Treatment of dermatophytosis in dogs and cats: review of published studies. | 2004 Apr |
|
Comparative assessment of the inhibition of recombinant human CYP19 (aromatase) by azoles used in agriculture and as drugs for humans. | 2004 Aug |
|
Development of an in vitro, isolated, infected spore testing model for disinfectant testing of Microsporum canis isolates. | 2004 Jun |
|
[Incidence, immunity and treatment of feline dermatophytosis]. | 2005 May |
|
Dysmorphogenic effects of some fungicides derived from the imidazole on rat embryos cultured in vitro. | 2006 Jan |
|
Surgical treatment of canine nasal aspergillosis by rhinotomy combined with enilconazole infusion and oral itraconazole. | 2006 Jun |
|
Combined clotrimazole irrigation and depot therapy for canine nasal aspergillosis. | 2006 Jun |
|
Identification of new human pregnane X receptor ligands among pesticides using a stable reporter cell system. | 2006 Jun |
|
Inhibition of rainbow trout (Oncorhynchus mykiss) P450 aromatase activities in brain and ovarian microsomes by various environmental substances. | 2006 Nov |
|
Comparison of lanosterol-14 alpha-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles. | 2006 Nov 10 |
|
Long-term outcomes in dogs with sinonasal aspergillosis treated with intranasal infusions of enilconazole. | 2007 Jan-Feb |
|
Correlation between digestion of the lipid phase of smedds and release of the anti-HIV drug UC 781 and the anti-mycotic drug enilconazole from smedds. | 2007 May |
|
Screening of 397 chemicals and development of a quantitative structure--activity relationship model for androgen receptor antagonism. | 2008 Apr |
|
Enilconazole treatment of horses with superficial Aspergillus spp. rhinitis. | 2008 Sep-Oct |
|
A zoospore inhibition technique to evaluate the activity of antifungal compounds against Batrachochytrium dendrobatidis and unsuccessful treatment of experimentally infected green tree frogs (Litoria caerulea) by fluconazole and benzalkonium chloride. | 2009 Aug |
|
A lufenuron pre-treatment may enhance the effects of enilconazole or griseofulvin in feline dermatophytosis? | 2009 Feb |
|
CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-comparison with other conazole pesticides. | 2009 Feb 10 |
|
Effects of the azole fungicide Imazalil on the development of the ascidian Ciona intestinalis (Chordata, Tunicata): morphological and molecular characterization of the induced phenotype. | 2009 Feb 19 |
|
A concentration addition model for the activation of the constitutive androstane receptor by xenobiotic mixtures. | 2009 Jan |
|
Antifungal activity of tea tree oil from Melaleuca alternifolia against Trichophyton equinum: an in vivo assay. | 2009 Nov |
|
Widely used pesticides with previously unknown endocrine activity revealed as in vitro antiandrogens. | 2011 Jun |
|
Potential of an in vitro toolbox combined with exposure data as a first step for the risk assessment of dietary chemical contaminants. | 2011 Sep |
|
Inhibitory effects of azole-type fungicides on interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ. | 2012 Mar 15 |
|
A concentration addition model to assess activation of the pregnane X receptor (PXR) by pesticide mixtures found in the French diet. | 2014 Sep |
|
Cell-Based High-Throughput Screening for Aromatase Inhibitors in the Tox21 10K Library. | 2015 Oct |
|
Effects of Common Pesticides on Prostaglandin D2 (PGD2) Inhibition in SC5 Mouse Sertoli Cells, Evidence of Binding at the COX-2 Active Site, and Implications for Endocrine Disruption. | 2016 Apr |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/vet/imaverol-can.html
The concentrated Imaverol (Enilconazole) is diluted in 50 parts of lukewarm water, which yields a 0.2% emulsion. Dispose of all unused diluted solutions.
Dermatophytes will extend into the hair follicles. Possible crusts must therefore be removed with a hard brush, which has been soaked in the diluted IMAVEROL emulsion. It is highly recommended that the animal be sprayed entirely at the first treatment so as to reach the subclinical lesions as well.
Horse: The lesions and surrounding skin are to be washed with the diluted emulsion 4 times at 3 to 4 day intervals.
Dog: The animals are to be washed with the diluted emulsion 4 times at 3 to 4 day intervals.
While doing this, one should rub thoroughly in the direction opposite to the hair growth to make sure that the skin is thoroughly wet. For the same reason, it is recommended to clip long-haired dogs prior to treatment.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22708367
A. niger strains were most susceptible to enilconazole. MIC ranged from 0.0625 to 0.5 ug/ml for enilconazole, with MIC90-0.5 ug/ml and MIC50-0.125 ug/ml.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:00:17 GMT 2023
by
admin
on
Fri Dec 15 15:00:17 GMT 2023
|
Record UNII |
6K0NOF3XQ6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C514
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
||
|
WHO-VATC |
QD01AC90
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
||
|
EPA PESTICIDE CODE |
111901
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
73790-28-0
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
SUPERSEDED | |||
|
4921
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
252-615-0
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
6672
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
1442172
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | RxNorm | ||
|
81927
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
51004-46-7
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
SUPERSEDED | |||
|
C017435
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
m4907
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | Merck Index | ||
|
35554-44-0
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
CHEMBL356918
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
759313
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
3177
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
SUB183414
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
1135441-05-2
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
SUPERSEDED | |||
|
3177
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
DTXSID8024151
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
imazalil
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
C81505
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
6K0NOF3XQ6
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
100000169713
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
6K0NOF3XQ6
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
37175
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
ENILCONAZOLE
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |